Pharmacokinetic (PK) and pharmacodynamics (PD) properties of SC-PEG e. coli L-asparaginase (EZN-2285) in the treatment of patients with acute lymphoblastic leukemia (ALL): Results from Children's Oncology Group (COG) study AALL07P4.
Anne L. Angiolillo
Research Funding - Sigma-Tau
Reuven J. Schore
Research Funding - Sigma-Tau
Gregory H. Reaman
Research Funding - Sigma-Tau
Naomi Joan Winick
Research Funding - Sigma-Tau
Meenakshi Devidas
Research Funding - Sigma-Tau
Hao W. Zheng
Research Funding - Sigma-Tau
Charlotte Wood
Research Funding - Sigma-Tau
Ashley R. Lane
Research Funding - Sigma-Tau
Elizabeth A. Raetz
Research Funding - Sigma-Tau
William L. Carroll
Research Funding - Sigma-Tau
Stephen Hunger
Research Funding - Sigma-Tau